The reference "Free Radical Biology of Endocrine, Metabolic & Immune disorders" uniquely explores the science of signalling mechanisms associated with diseases like endocrine, metabolic, and immune ...

Diagnosing an endocrine disorder can be challenging because symptoms often mimic those of other conditions, and treatment plans can be complex. That’s why people with an endocrine disease need to see ...

In recent years, nanoplastic and microplastic particles (NMPs) have emerged as substantial threats to human health, particularly as endocrine disruptors. The endocrine system is especially vulnerable ...

Researchers have revealed a reason why endocrine resistance develops in breast cancers and how to potentially treat it in patients. Endocrine resistance -- a major cause of breast cancer deaths -- can ...

1 Centre for Critical Illness Research, Lawson Health Research Institute; 2 Division of Respirology, 3 Department of Medicine, 4 Department of Physiology and Pharmacology, Schulich School of Medicine ...

Hormones are vital for maintaining normal health, growth, development and various other aspects of the body. Either excessive or deficient secretion of hormones can therefore cause diseases and ...

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function ...

APS (Acta Pharmacologica Sinica) publishes high quality content in all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer ...

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and ...

Endocrine glands secrete hormones into the bloodstream, while exocrine glands secrete substances, such as sweat or enzymes, into organs or onto the surface of the body. The two main types of glands in ...

SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026 after the ...